Muraleedharan, T. et al. 2026. Residual Inflammatory Risk in Atherosclerotic Cardiovascular Disease: Is Anti-Inflammatory Therapy the Next Frontier Beyond LDL Reduction?. International Journal of Medical Students. (Aug. 2026).